ResMed Cash Beginning of Year Trend

RMD -- USA Stock  

USD 113.43  0.67  0.59%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

ResMed Fundamental Drivers

ResMed Fundamental Market Drivers

Short Percent Of Float2.21%
Forward Price Earnings26.69
Shares Short Prior Month3.76M
Average Daily Volume Last 10 Day942.35k
Average Daily Volume In Three Month661.11k
Date Short InterestJuly 13, 2018
Fifty Day Average107.02
Two Hundred Day Average100.74

ResMed Upcoming Events

ResMed Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017
Additionally take a look at analysis of ResMed Correlation with competitors. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com